OBJECTIVE: To examine changes in diabetes-related preventable hospitalization costs and to determine the contribution of each underlying factor to these changes. RESEARCH DESIGN AND METHODS: We used data from the 2001-2014 U.S. National (Nationwide) Inpatient Sample (NIS) for adults (≥18 years old) to estimate the trends in hospitalization costs (2014 USD) in total and by condition (short-term complications, long-term complications, uncontrolled diabetes, and lower-extremity amputation). Using regression and growth models, we estimated the relative contribution of following underlying factors: total number of hospitalizations, rate of hospitalization, the number of people with diabetes, mean cost per admission, length of stay, and cost per day. RESULTS: During 2001-2014, the estimated total cost of diabetes-related preventable hospitalizations increased annually by 1.6% (92.9 million USD; P < 0.001). Of this 1.6% increase, 75% (1.2%) was due to the increase in the number of hospitalizations, which is a result of a 3.8% increase in diabetes population and a 2.6% decrease in the hospitalization rate, and 25% (0.4%) was due to the increase in cost per admission, for a net result of a 1.6% increase in cost per day and a 1.3% decline in mean length of stay. By component, the cost of short-term complications, lower-extremity amputations, and long-term complications increased annually by 4.2, 1.9, and 1.5%, respectively, while the cost of uncontrolled diabetes declined annually by 2.6%. CONCLUSIONS: The total cost of diabetes-related preventable hospitalizations had been increasing during 2001-2014, mainly resulting from increases in number of people with diabetes and cost per hospitalization day. The underlying factors identified in our study could lead to efforts that may lower future hospitalization costs.
OBJECTIVE: To examine changes in diabetes-related preventable hospitalization costs and to determine the contribution of each underlying factor to these changes. RESEARCH DESIGN AND METHODS: We used data from the 2001-2014 U.S. National (Nationwide) Inpatient Sample (NIS) for adults (≥18 years old) to estimate the trends in hospitalization costs (2014 USD) in total and by condition (short-term complications, long-term complications, uncontrolled diabetes, and lower-extremity amputation). Using regression and growth models, we estimated the relative contribution of following underlying factors: total number of hospitalizations, rate of hospitalization, the number of people with diabetes, mean cost per admission, length of stay, and cost per day. RESULTS: During 2001-2014, the estimated total cost of diabetes-related preventable hospitalizations increased annually by 1.6% (92.9 million USD; P < 0.001). Of this 1.6% increase, 75% (1.2%) was due to the increase in the number of hospitalizations, which is a result of a 3.8% increase in diabetes population and a 2.6% decrease in the hospitalization rate, and 25% (0.4%) was due to the increase in cost per admission, for a net result of a 1.6% increase in cost per day and a 1.3% decline in mean length of stay. By component, the cost of short-term complications, lower-extremity amputations, and long-term complications increased annually by 4.2, 1.9, and 1.5%, respectively, while the cost of uncontrolled diabetes declined annually by 2.6%. CONCLUSIONS: The total cost of diabetes-related preventable hospitalizations had been increasing during 2001-2014, mainly resulting from increases in number of people with diabetes and cost per hospitalization day. The underlying factors identified in our study could lead to efforts that may lower future hospitalization costs.
Authors: Héctor Bueno; Joseph S Ross; Yun Wang; Jersey Chen; María T Vidán; Sharon-Lise T Normand; Jeptha P Curtis; Elizabeth E Drye; Judith H Lichtman; Patricia S Keenan; Mikhail Kosiborod; Harlan M Krumholz Journal: JAMA Date: 2010-06-02 Impact factor: 56.272
Authors: Bruce C Stuart; Linda Simoni-Wastila; Lirong Zhao; Jennifer T Lloyd; Jalpa A Doshi Journal: Diabetes Care Date: 2009-01-26 Impact factor: 17.152
Authors: Linda S Geiss; Jing Wang; Yiling J Cheng; Theodore J Thompson; Lawrence Barker; Yanfeng Li; Ann L Albright; Edward W Gregg Journal: JAMA Date: 2014-09-24 Impact factor: 56.272
Authors: A Calderón-Larrañaga; M Soljak; E Cecil; J Valabhji; D Bell; A Prados Torres; A Majeed Journal: Diabet Med Date: 2014-03-26 Impact factor: 4.359
Authors: Marlene Garcia; Brian Hernandez; Tyler G Ellington; Anupama Kapadia; Joel Michalek; Susan Fisher-Hoch; Joseph B McCormick; Anand Prasad Journal: Diabetes Care Date: 2019-04-09 Impact factor: 19.112
Authors: Oleg Zaslavsky; Onchee Yu; Rod L Walker; Paul K Crane; Shelly L Gray; Tatiana Sadak; Soo Borson; Eric B Larson Journal: J Gerontol A Biol Sci Med Sci Date: 2021-10-13 Impact factor: 6.053
Authors: Drew A Helmer; Nilanjana Dwibedi; Mazhgan Rowneki; Chin-Lin Tseng; Dennis Fried; Danielle Rose; Nisha Jani; Usha Sambamoorthi Journal: Am Health Drug Benefits Date: 2020-05